ANP inhibits TNF-α-induced endothelial MCP-1 expression involvement of p38 MAPK and MKP-1

Journal of Leukocyte Biology

Volumn 74, Issue 5, 2003, Pages 932-941

  Weber, Nina C ^a   Blumenthal, Signe B ^a   Hartung, Thomas ^b   Vollmar, Angelika M ^a   Kiemer, Alexandra K ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Chemokines; Cytokines; Endothelial cells; Inflammation; Natruiretic peptides

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; GLUTATHIONE DERIVATIVE; GUANYLATE CYCLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NATRIURETIC PEPTIDE TYPE C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; RAT; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

ATRIAL NATRIURETIC FACTOR; CELL CYCLE PROTEINS; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GUANYLATE CYCLASE; HOMEOSTASIS; IMIDAZOLES; IMMEDIATE-EARLY PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE DONORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; PYRIDINES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

ANIMALIA;

EID: 0347361650     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0603254     Document Type: Article

References (65)

1. Tremblay, J., Desjardins, R., Hum, D., Gutkowska, J., Hamet, P. (2002) Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell. Biochem. 230, 31-47.
2. Levin, E. R. (1993) Natriuretic peptide C-receptor: more than a clearance receptor. Am. J. Physiol. 264, E483-E489.
3. Levin, E. R., Frank, H. J. (1991) Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am. J. Physiol. 261, R453-R457.
4. Hu, R. M., Levin, E. R., Pedram, A., Frank, H. J. (1992) Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J. Biol. Chem. 267, 17384-17389.
5. Kiemer, A. K., Lehner, M. D., Hartung, T., Vollmar, A. M. (2002) Inhibition of cyclooxygenase-2 by natriuretic peptides. Endocrinology 143, 846-852.
6. Vollmar, A. M., Schullz, R. (1994) Gene expression and secretion of atrial natriuretic peptide by murine macrophages. J. Clin. Invest. 94, 539-545.
7. Vollmar, A. M., Schulz, R. (1995) Expression and differential regulation of natriuretic peptides in mouse macrophages. J. Clin. Invest. 95, 2442-2450.
8. Kiemer, A. K., Vollmar, A. M. (1997) Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Endocrinology 138, 4282-4290.
9. Kiemer, A. K., Baron, A., Gerbes, A. L., Bilzer, M., Vollmar, A. M. (2002) The atrial natriuretic peptide as a regulator of Kupffer cell functions. Shock 17, 365-371.
10. Kiemer, A. K., Vollmar, A. M. (1998) Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J. Biol. Chem. 273, 13444-13451.
11. Kiemer, A. K., Vollmar, A. M. (2001) Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide. Immunol. Cell Biol. 79, 11-17.
12. Kiemer, A. K., Vollmar, A. M. (2001) Induction of L-arginine transport is inhibited by ANP: a peptide hormone as a novel regulator of iNOS substrate availability. Mol. Pharmacol. 60, 421-426.
13. Kiemer, A. K., Hartung, T., Vollmar, A. M. (2000) cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J. Immunol. 165, 175-181.
14. Kiemer, A. K., Vollmar, A. M., Bilzer, M., Gerwig, T., Gerbes, A. L. (2000). Atrial natriuretic peptide reduces expression of TNF-alpha tuRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J. Hepatol. 33, 236-246.
15. Tsukagoshi, H., Shimizu, Y., Kawata, T., Hisada, T., Shimizu, Y., Iwamae, S., Ishizuka, T., Iizuka, K., Dobashi, K., Mori, M. (2001) Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation. Regul. Pept. 99, 21-29.
16. Robinson, E. A., Yoshimura, T., Leonard, E. J., Tanaka, S., Griffin, P. R., Shabanowitz, J., Hunt, D. F., Appella, E. (1989) Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc. Natl. Acad. Sci. USA 86, 1850-1854.
17. Folkard, S. G., Westwick, J., Millar, A. B. (1997) Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur. Respir. J. 10, 2097-2104.
18. Sousa, A. R., Lane, S. J., Nakhosteen, J. A., Yoshimura, T., Lee, T. H., Poston, R. N. (1994) Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 10, 142-147.
19. Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281.
20. Reape, T. J., Groot, P. H. (1999) Chemokines and atherosclerosis. Atherosclerosis 147, 213-225.
21. Kiemer, A. K., Weber, N. C., Fürst, R., Bildner, N., Kulhanek-Heinze, S., Vollmar, A. M. (2002) Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ. Res. 90, 874-881.
22. Kiemer, A. K., Weber, N. C., Volhnar, A. M. (2002) Induction of IkappaB: atrial natriuretic peptide as a regulator of the NF-kappaB pathway. Biochem. Biophys. Res. Commun. 295, 1068-1076.
23. Ludwig, S., Hoffmeyer, A., Goebeler, M., Kilian, K., Hafner, H., Neufeld, B., Han, J., Rapp, U. R. (1998) The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem. 273, 1917-1922.
24. Kiemer, A. K., Bildner, N., Weber, N. C., Vollmar, A. M. (2003) Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 144, 802-812.
25. Takanami-Ohnishi, Y., Amano, S., Kimura, S., Asada, S., Utani, A., Maruyama, M., Osada, H., Tsunoda, H., Irukayama-Tomobe, Y., Goto, K., Karin, M., Sudo, T., Kasuya, Y. (2002) Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity. J. Biol. Chem. 277, 37896-37903.
26. Xiao, Y. Q., Malcoln, K., Worthen, G. S., Gardai, S., Schiemann, W. P., Fadok, V. A., Bratton, D. L., Henson, P. M. (2002) Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J. Biol. Chem. 277, 14884-111893.
27. Takaishi, H., Taniguchi, T., Takahashi, A., Ishikawa, Y., Yokoyama, M. (2003) High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem. Biophys. Res. Commun. 305, 122-128.
28. Roebuck, K. A., Carpenter, L. R., Lakshminarayanan, V., Page, S. M., Moy, J. N., Thomas, L. L. (1999) Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors A P-1 and NF-kappaB. J. Luekoc. Biol. 65, 291-298.
29. Teifel, M., Heien, L. T., Milbredt, S., Friedl, P. (1997) Optimization of transfection of human endothelial cells. Endothelium 5, 21-35.
30. Namiki, M., Kawashima, S., Yamashita, T., Ozaki, M., Hirase, T., Ishida, T., Inoue, N., Hirata, K., Matsukawa, A., Morishita, R., Kaneda, Y., Yokoyama, M. (2002) Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 22, 115-120.
31. Yla-Herttuala S., Lipton, B. A., Rosenfeld, M. E., Sarkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., Steinberg, D. (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88, 5252-5256.
32. Nelken, N. A., Coughlin, S. R., Gordon, D., Wilcox, J. N. (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88, 1121-1127.
33. Seli, E., Pehlivan, T., Selam, B., Garcia-Velasco, J. A., Arici, A. (2002) Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil. Steril. 77, 542-547.
34. Weiss, J. M., Cuff, C. A., Berman, J. W. (1999) TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-1 expression in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression. Endothelium 6, 291-302.
35. Nakamura, H., Herzenberg, L. A., Bai, J., Araya, S., Kondo, N., Nishinaka, Y., Herzenberg, L. A., Yodoi, J. (2001) Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc. Natl. Acad. Sci. USA 98, 15143-15148.
36. Wang, D. L., Wung, B. S., Shyy, Y. J., Lin, C. F., Chao, Y. J., Usami, S., Chien, S. (1995) Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells. Circ. Res. 77, 294-302.
37. Okada, M., Matsumori, A., Ono, K., Furukawa, Y., Shioi, T., Iwasaki, A., Matsushima, K., Sasayama, S. (1998) Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18, 894-901.
38. Draijer, R., Vaandrager, A. B., Nolte, C., de Jonge, H. R., Walter, U., van Hinsbergh, V. W. (1995) Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ. Res. 77, 897-905.
39. Smolenski, A., Poller, W., Walter, U., Lohmann, S. M. (2000) Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I. J. Biol. Chem. 275, 25723-25732.
40. Redondo, J., Bishop, J. E., Wilkins, M. R. (1998) Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br. J. Pharmacol. 124, 1455-1462.
41. Shimizu, K., Shintani, Y., Ding, W. G., Matsuura, H., Bamba, T. (2002) Potentiation of slow component of delayed rectifier K(+) current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G. Br. J. Pharmacol. 137, 127-137.
42. Tanaka, Y., Aida, M., Tanaka, H., Shigenobu, K., Toro, L. (1998) Involvement of maxi-K(Ca) channel activation in atrial natriuretic peptide-induced vasorelaxation. Naunyn Schmiedebergs Arch. Pharmacol. 357, 705-708.
43. Hirsch, J. R., Meyer, M., Magert, H. J., Forssmann, W. G., Mollerup, S., Herter, P., Weber, G., Cermak, R., Ankorina-Stark, I., Schlatter, E., Kruhoffer, M. (1999) cGMP-dependent and -independent inhibition of a K+ conductance by natriuretic peptides: molecular and functional studies in human proximal tubule cells. J. Am. Soc. Nephrol. 10, 472-480.
44. Bao, X., Lu, C., Frangos, J. A. (1999) Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expression in endothelial cells: role of NO, NF kappa B, and egr-1. Arterioscler. Thromb. Vasc. Biol. 19, 996-1003.
45. Preli, R. B., Klein, K. P., Herrington, D. M. (2002) Vascular effects of dietary L-arginine supplementation. Atherosclerosis 162, 1-15.
46. Zeiher, A. M., Fisslthaler, B., Schray-Utz, B., Busse, R. (1995) Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76, 980-986.
47. Ito, W. D., Arras, M., Winkler, B., Scholz, D., Schaper, J., Schaper, W. (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80, 829-837.
48. Yamagishi, S. I., Edelstein, D., Du, X. L., Kaneda, Y., Guzman, M., Brownlee, M. (2001) Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 276, 25096-25100.
49. Shyy, Y. J., Li, Y. S., Kolattukudy, P. E. (1993) Activation of MCP-1 gene expression is mediated through multiple signaling pathways. Biochem. Biophys. Res. Commun. 192, 693-699.
50. Pasceri, V., Cheug, J. S., Willerson, J. T., Yeh, E. T., Chang, J. (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103, 2531-2534.
51. Reddy, S., Hama, S., Grijalva, V., Hassan, K., Mottahedeh, R., Hough, G., Wadleigh, D. J., Navab, M., Fogehnan, A. M. (2001) Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. J. Biol. Chem. 276, 17030-17035.
52. Kiemer, A. K., Kulhanek-Heinze, K., Gerwig, T., Gerbes, A. L., Vollmar, A. M. (2002) Stimulation of p38 MAPK by hormonal preconditioning with atrial natriuretic peptide. World J. Gastroenterol. 8, 707-711.
53. Carini, R., De Cesaris, M. G., Splendore, R., Domenicotti, C., Nitti, M. P., Pronzato, M. A., Albano, E. (2003) Mechanisms of hepatocyte protection against hypoxic injury by atrial natriuretic peptide. Hepatology 37, 277-285.
54. Pedram, A., Razandi, M., Levin, E. R. (2001) Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 142, 1578-1586.
55. Schwenger, P., Alpert, D., Skolnik E. Y., Vilcek, J. (1998) Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol. Cell. Biol. 18, 78-84.
56. Alpert, D., Schwenger, P., Han, J., Vilcek, J. (1999) Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor neurosis factor-induced IkappaB phosphorylation and NF-kappaB activation. J. Biol. Chem. 274, 22176-22183.
57. Birkenkamp, K. U., Tuyt, L. M., Lummen, C., Wierenga, A. T., Kruijer, W., Vellenga, E. (2000) The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br. J. Pharmacol. 131, 99-107.
58. Carcamo, J. M., Pedraza, A., Borquez-Ojeda, O., Golde, D. W. (2002) Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting 1 kappa B alpha phosphorylation. Biochemistry 41, 12995-13002.
59. Tsai, P. W., Shiah, S. G., Lin, M. T., Wu, C. W., Kuo, M. L. (2003) Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J. Biol. Chem. 278, 5750-5759.
60. Aiura, K., Ueda, M., Endo, M., Kitajima, M. (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit. Care Med. 23, 1898-1906.
61. Hama, N, Mori, H, Shirakami, G., Suga, S., Koniatsu, Y., Yoshimasa, T., Tanaka, I., Mori, K., Nakao, K. (1994) Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem. Biophys. Res. Commun. 198, 1177-1182.
62. Hartermink, K. J., Groneveld, A. B., de Groot, M. C., Strack van Schijndel, R. J., van Kamp, G., Thijs, L. C. (2001) Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit. Care Med. 29, 1898-1906.
63. Rubinstein, I., Hong, D. (1999) Circulating natriuretic peptides: a biologic marker of tissue injury? Chest 115, 7-8.
64. Quasclming, T., Galle, J., Wanner, C. (2003) Vasopeptidase inhibition: a new treatment approach for endothelial dysfunction. Kidney Int. Suppl. May, 54-57.
65. Gruchala, M., Ciecwierz, D, Wasag, B., Targonski, R., Dubaniewicz, W., Nowak, A., Sobiczewski, W., Ochman, K., Romanowski, P., Linion, J., Rynkiewicz, A. (2003) Association of the Seal atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am. Heart J. 145, 125-131.